Arnulf Dorn

2.9k citations

27 papers · 2.4k indexed · 2 hit papers · h-index 19

Public Health, Environmental and Occupational Health top 1%
Molecular Biology top 10%
Organic Chemistry top 5%
Computational Theory and Mathematics top 1%
Oncology top 10%

Co-authors: Jacques Bollekens Diane Mathis Christophe Benoıst Jonathan L. Vennerstrom Hugues Matile Robert G. Ridley Sudha Rani Vippagunta C Jaquet
Topics: Malaria Research and Control (18 papers)Research on Leishmaniasis Studies (8 papers)Computational Drug Discovery Methods (7 papers)
Cited by: Public Health, Environmental and Occupational Health Computational Theory and Mathematics Parasitology
Journals: Nature Cell Journal of Medicinal Chemistry
Partner nations: Switzerland United States Australia

In The Last Decade

Arnulf Dorn

27 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multiplicity of CCAAT box-binding proteins

1987 706 citations Arnulf Dorn et al. profile →
Identification of an antimalarial synthetic trioxolane drug development candidate

2004 507 citations Jonathan L. Vennerstrom, Sarah Arbe‐Barnes et al. Nature profile →

Peers

Countries citing papers authored by Arnulf Dorn

Since Specialization

Citations

This map shows the geographic impact of Arnulf Dorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnulf Dorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnulf Dorn more than expected).

Fields of papers citing papers by Arnulf Dorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnulf Dorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnulf Dorn. The network helps show where Arnulf Dorn may publish in the future.

Co-authorship network of co-authors of Arnulf Dorn

This figure shows the co-authorship network connecting the top 25 collaborators of Arnulf Dorn. A scholar is included among the top collaborators of Arnulf Dorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnulf Dorn. Arnulf Dorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The comparative antimalarial properties of weak base and neutral synthetic ozonides 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yuanqing Tang,Sergio Wittlin,Susan A. Charman,Jacques Chollet,Francis C. K. Chiu,Julia Morizzi,Lisa M. Johnson,(unknown),Christian Scheurer,(unknown),Lin Zhou,Yuxiang Dong,William N. Charman,Hugues Matile,Heinrich Urwyler,Arnulf Dorn,Jonathan L. Vennerstrom	10
2	The Structure−Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277) 2009 ·Journal of Medicinal Chemistry ·Yuxiang Dong,Sergio Wittlin,K. Sriraghavan,Jacques Chollet,Susan A. Charman,William N. Charman,Christian Scheurer,Heinrich Urwyler,(unknown),Christopher M. Snyder,Darren J. Creek,Julia Morizzi,Maria Koltun,Hugues Matile,Xiaofang Wang,Maniyan P. Padmanilayam,Yuanqing Tang,Arnulf Dorn,Reto Brun,Jonathan L. Vennerstrom	79
3	Weak base dispiro-1,2,4-trioxolanes: Potent antimalarial ozonides 2006 ·Bioorganic & Medicinal Chemistry Letters ·Yuanqing Tang,Yuxiang Dong,Sergio Wittlin,Susan A. Charman,Jacques Chollet,Francis C. K. Chiu,William N. Charman,Hugues Matile,Heinrich Urwyler,Arnulf Dorn,(unknown),Xiaofang Wang,Maniyan P. Padmanilayam,Jean M. Karle,Reto Brun,Jonathan L. Vennerstrom	49
4	Evaluation of a High-Throughput Fluorescence Assay Method for hERG Potassium Channel Inhibition 2005 ·SLAS DISCOVERY ·Arnulf Dorn,(unknown),Andreas Ebneth,Hendrick Bothmann,Gerhard Trube,Klaus Christensen,Christian Apfel	44
5	Subclasses of Simian-Virus-40 Large Tumor Antigen 2005 ·European Journal of Biochemistry ·Arnulf Dorn,(unknown),Bernd Otto,Ellen Fanning,Rolf Knippers	1
6	Identification of an antimalarial synthetic trioxolane drug development candidatebreakdown → 2004 ·Nature ·Jonathan L. Vennerstrom,Sarah Arbe‐Barnes,Reto Brun,Susan A. Charman,Francis C. K. Chiu,Jacques Chollet,Yuxiang Dong,Arnulf Dorn,Daniel Hunziker,Hugues Matile,Kylie A. McIntosh,Maniyan P. Padmanilayam,(unknown),Christian Scheurer,Bernard Scorneaux,Yuanqing Tang,Heinrich Urwyler,Sergio Wittlin,William N. Charman	507
7	SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture 2003 ·Cytotechnology ·Ernst‐Jürgen Schlaeger,Eric Kitas,Arnulf Dorn	27
8	Carbon Isosteres of the 4-Aminopyridine Substructure of Chloroquine: Effects on pK_a, Hematin Binding, Inhibition of Hemozoin Formation, and Parasite Growth 2003 ·Journal of Medicinal Chemistry ·(unknown),Souvik Maiti,Arnulf Dorn,Bernard Scorneaux,Apurba K. Bhattacharjee,William Y. Ellis,Jonathan L. Vennerstrom	47
9	Development of a New Class of Inhibitors for the Malarial Aspartic Protease Plasmepsin II Based on a Central 7‐Azabicyclo[2.2.1]heptane Scaffold 2003 ·Helvetica Chimica Acta ·David A. Carcache,(unknown),Paul Seiler,François Diederich,Arnulf Dorn,Hans Peter Märki,Christoph A. Binkert,Daniel Bur	21
10	De Novo Design, Synthesis, and In Vitro Evaluation of a New Class of Nonpeptidic Inhibitors of the Malarial Enzyme Plasmepsin II 2002 ·ChemBioChem ·David A. Carcache,(unknown),(unknown),Christoph A. Binkert,Daniel Bur,Hans Peter Märki,Arnulf Dorn,François Diederich	32
11	Tris-benzimidazole derivatives: design, synthesis and DNA sequence recognition 2001 ·Bioorganic & Medicinal Chemistry ·Yuhua Ji,Daniel Bur,(unknown),(unknown),Arnulf Dorn,Christian Bailly,Michael J. Waring,Remo Hochstrasser,Werner Leupin	32
12	Deferoxamine: Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine 1999 ·Biochemical Pharmacology ·Sudha Rani Vippagunta,Arnulf Dorn,(unknown),Robert G. Ridley,Jonathan L. Vennerstrom	21
13	8-Aminoquinolines Active against Blood Stage Plasmodium falciparum In Vitro Inhibit Hematin Polymerization 1999 ·Antimicrobial Agents and Chemotherapy ·Jonathan L. Vennerstrom,Edwin O. Nuzum,Robert E. Miller,Arnulf Dorn,Lucia Gerena,Prasad Dande,William Y. Ellis,Robert G. Ridley,Wilbur K. Milhous	80
14	Structural Specificity of Chloroquine−Hematin Binding Related to Inhibition of Hematin Polymerization and Parasite Growth 1999 ·Journal of Medicinal Chemistry ·Sudha Rani Vippagunta,Arnulf Dorn,Hugues Matile,Apurba K. Bhattacharjee,Jean M. Karle,William Y. Ellis,Robert G. Ridley,Jonathan L. Vennerstrom	129
15	A Comparison and Analysis of Several Ways to Promote Haematin (Haem) Polymerisation and an Assessment of Its Initiation In Vitro 1998 ·Biochemical Pharmacology ·Arnulf Dorn,Sudha Rani Vippagunta,Hugues Matile,(unknown),Jonathan L. Vennerstrom,Robert G. Ridley	85
16	Studies on Plasmepsins I and II from the Malarial Parasite Plasmodium falciparum and their Exploitation as Drug Targets 1998 ·Advances in experimental medicine and biology ·Richard P. Moon,Daniel Bur,Hansruedi Loetscher,A. D’Arcy,Lorraine Tyas,Christian Oefner,(unknown),Daniel Mona,(unknown),Arnulf Dorn,Hugues Matile,Ulrich Certa,Colin Berry,John Kay,Robert G. Ridley	15
17	An Assessment of Drug-Haematin Binding as a Mechanism for Inhibition of Haematin Polymerisation by Quinoline Antimalarials 1998 ·Biochemical Pharmacology ·Arnulf Dorn,Sudha Rani Vippagunta,Hugues Matile,C Jaquet,Jonathan L. Vennerstrom,Robert G. Ridley	260
18	Homeodomain proteins in development and therapy 1994 ·Pharmacology & Therapeutics ·Arnulf Dorn,Markus Affolter,Walter J. Gehring,Werner Leupin	17
19	Short Optimally Capped Duplex DNA as Conformationally Restricted Analogue of B‐DNA 1994 ·Helvetica Chimica Acta ·Willi Bannwarth,Arnulf Dorn,(unknown),(unknown)	15
20	The enhancer in an MHC class II gene, in vitro and in mouso 1988 ·Biochimie ·(unknown),(unknown),Arnulf Dorn,(unknown),(unknown),Werner Koch,Caroline Waltzinger,Christophe Benoist,(unknown)	2

About Arnulf Dorn

Arnulf Dorn is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Molecular Biology, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Malaria Research and Control (18 papers), Research on Leishmaniasis Studies (8 papers) and Computational Drug Discovery Methods (7 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (1.1k citations), Computational Theory and Mathematics (438 citations) and Parasitology (126 citations). Arnulf Dorn has collaborated with scholars based in Switzerland, United States and Australia. Frequent co-authors include Jacques Bollekens, Diane Mathis, Christophe Benoıst, Jonathan L. Vennerstrom, Hugues Matile, Robert G. Ridley, Sudha Rani Vippagunta, C Jaquet, Heinrich Urwyler and Reto Brun. Their work appears in journals such as Nature, Cell and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact